Parkes Lab Oxford Institute of Radiation Oncology. Cancer Immunology research, innate immune pathways, working towards better science = better cancer treatment
Oxford
Joined September 2019
- Tweets25
- Following394
- Followers396
- Likes121
Parkes Lab retweeted
Excited to share the first @olcina_lab preprint where we describe how C5aR1 regulates cancer cell fate and can be targeted to improve radiotherapy even in tumours with immunosuppressive features. biorxiv.org/cgi/content/shor… #bioRxiv
Many thanks to @olcina_lab and collaborators!
Parkes Lab retweeted
Thrilled to have had the opportunity to represent @ParkesLab and present my work at the DNA-damage response in cell physiology and disease workshop in Sounio. An incredible venue with amazing science and even better people. #EMBODNAdamage – at Greece
Parkes Lab retweeted
@eileen_parkes from @ParkesLab modifies the concept of Swiss cheese models to highlight all the constituent parts that need to come together for an effective tumour response - love this concept #OIS2022
Parkes Lab retweeted
😊😊 Thank you so much Eileen @eileen_parkes. Grateful for your immense support. If anyone’s interested in Tumor immunology/DNA damage, I highly recommend the @ParkesLab. Super smart and supportive people!
This Post is from an account that no longer exists. Learn more
Parkes Lab retweeted
.@eileen_parkes is a researcher.
You helped us save research like Dr Parkes' by raising almost £2m to keep work going in lockdown.
But we can't stop now. The end of the pandemic may be in sight, but prostate cancer is as big a threat as ever.
Donate ➡️ bit.ly/3odAEzj
Parkes Lab retweeted
We talk to @sharib_m from @bdi_oxford in our new blog about the challenges in the early detection of oesophageal cancer
Sharib is improving the accuracy of endoscopic diagnosis through the use of AI technologies and global AI collaborations
Read more👇
bit.ly/2WjAXw8
Parkes Lab retweeted
The first #CheckpointInhibition review explores #TIGIT as a novel checkpoint. From structural biology and expression, to mechanism and the clinical potential of TIGIT inhibition.
Thanks Dr Harjunpää & Dr @CGuillerey!
👉 bit.ly/35LaquT
@CEIjournal
#immunotherapy
#cancer
Parkes Lab retweeted
Very thoughtful and valuable thoughts! Thank you @rosslevinemd
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Parkes Lab retweeted
1. nature.com/articles/s41591-0… New work from the group describing transcriptomic analysis of CD8 responses to immune checkpoint blockade in melanoma. We find genes encoding TCR are over-expressed in samples from melanoma patients who proceed to have a sustained response to treatment
Parkes Lab retweeted
If you're looking for who to thank for this viral @BillNye moment... on behalf of @PCFnews, we'd like to say: "You're welcome." 🙃 #BlueJacketFashionShow @tbjfashionshow
This Post is from an account that no longer exists. Learn more
Parkes Lab retweeted
@CD_AACR starting off 2020 strong with the first-in-human trial of A2AR blockade for #immunotherapy, the first report of a clinical #KRAS G12C inhibitor (first online during #Targets19), content from @LabMassague, @derlabunc, @michele_teng, @Samuel_Bakhoum, and more!
Parkes Lab retweeted
Fancy an alternative #AdventCalendar...? Check out our science themed #CountdownToChristmas
What's behind door number one?
👉oncology.ox.ac.uk/advent
#STEMadvent #CancerResearch #DNA #Hypoxia
Parkes Lab retweeted
Save the date 12-15th July 2020 for the Annual Meeting of the ARR in Leeds @LeedsRTresearch @MCRCnews @The_OIRO @CRUKGlasgow @CRUK_CI @royalmarsdenNHS @ICR_London @CRUKLondon @uclh @TheCrick @KingsCollegeLon @QMULBartsTheLon
eu.eventscloud.com/ehome/arr…
Parkes Lab retweeted
Are you a basic or clinical researcher? Do you need to develop your understanding of transcriptomic data analysis with R? Join us for the Rbio Data Analysis course...register by 21 October
oncology.ox.ac.uk/event/rbio…
